“ALS Biomarkers for Therapy Development”

Benatar et al outlined a conceptual framework for ALS biomarker development in the paper titled “ALS biomarkers for therapy development: State of the field and future directions”

The authors articulated the nuanced but important point that the use of biomarkers must be “fit for purpose.”